Soluble IL-6R levels were significantly increased in COPD patients compared to S. These results indicate a potential role for IL-6 trans-signaling and CCL3 in COPD pulmonary inflammation. This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.